Joel Greenblatt’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Joel Greenblatt's SMMT Position: Q3 2026 in Review
Joel Greenblatt increased its Summit Therapeutics (SMMT) stake by 112% in Q3 2026, buying an estimated $263K and bringing the position to 33,333 shares worth $564K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.
Joel Greenblatt first reported a position in SMMT in Q2 2024 and has held it in 10 quarters since. 298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Joel Greenblatt held 33,333 shares of Summit Therapeutics worth $564K as of Q3 2026.
- Joel Greenblatt bought 17,606 Summit Therapeutics shares in Q3 2026, an estimated $263K.
- Summit Therapeutics made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1560 holding.
- Joel Greenblatt first reported a position in Summit Therapeutics in Q2 2024 and has held it in 10 quarters since.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.